<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head><title>
	Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives
</title><meta charset="utf-8" /><meta http-equiv="X-UA-Compatible" content="IE=edge" /><meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" /><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="format-detection" content="telephone=no" /><meta name="robots" content="all" /><link href="//www.scirp.org/favicon.ico" rel="shortcut icon" /><meta name="MSSmartTagsPreventParsing" content="True" /><meta http-equiv="MSThemeCompatible" content="Yes" />
    <script type="text/javascript" src="//www.scirp.org/js/jquery.js"></script>
    <link href="//www.scirp.org/css/bootstrap.min.css" rel="stylesheet" /><link href="//www.scirp.org/css/font-awesome.min.css" rel="stylesheet" /><link href="//www.scirp.org/css/styletwo.css" rel="stylesheet" /><link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet" /><link href="https://fonts.googleapis.com/css?family=Poppins:300,500,600,700,800" rel="stylesheet" />
    <script src="//www.scirp.org/js/modernizr.js" type="text/javascript"></script>   

    
    <link rel="alternate" type="application/pdf" title="PDF Full-Text" href="//www.scirp.org/pdf/OJMC_2015093009422941.pdf" />

    
    <link rel="alternate" type="text/html" title="HTML Full-Text" href="//www.scirp.org/journal/paperinformation?paperid=60062" />
    
    <link rel="alternate" type="text/xml" title="XML Full-Text" href="//www.scirp.org/xml/60062.xml" />
    
    <link rel="canonical" href="https://www.scirp.org/journal/paperinformation?paperid=60062" />


<meta property="og:site_name" content="SCIRP" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://www.scirp.org/journal/paperinformation?paperid=60062" />
<meta property="og:title" content="Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives" />


<meta property="og:image" content="https://file.scirp.org/image/OJMC2025010716370336.png" />
<meta property="og:image:secure_url" content="https://file.scirp.org/image/OJMC2025010716370336.png" />





 <script type="text/javascript">

     var ajaxj = {
         tryList: function () {
             var xhrj = null;
             for (var i = 0; i < arguments.length; i++) {
                 var lambda = arguments[i];
                 try { xhrj = lambda(); break; } catch (e) { }
             }
             return xhrj;
         },
         init: function () {
             return this.tryList(
         function () { return new ActiveXObject('MSXML2.XMLHttp.6.0'); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.3.0'); },
         function () { return new XMLHttpRequest(); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.5.0'); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.4.0'); },
         function () { return new ActiveXObject('Msxml2.XMLHTTP'); },
         function () { return new ActiveXObject('MSXML.XMLHttp'); },
         function () { return new ActiveXObject('Microsoft.XMLHTTP'); }
         ) || null;
         },
         post: function (sUrl, sArgs, bAsync, fCallBack, errmsg) {
             var xhrj = this.init();
             xhrj.onreadystatechange = function () {
                 if (xhrj.readyState == 4) {

                     if (xhrj.responseText) {
                         if (fCallBack.constructor == Function) { fCallBack(xhrj); }
                     } else {

                     }
                 }
             };
             xhrj.open('POST', encodeURI(sUrl), bAsync);

             xhrj.setRequestHeader('Content-Type', 'application/x-www-form-urlencoded');
             xhrj.send(sArgs);
         },
         get: function (sUrl, bAsync, fCallBack, errmsg) {
             var xhrj = this.init();
             xhrj.onreadystatechange = function () {
                 if (xhrj.readyState == 4) {
                     if (xhrj.responseText) {
                         if (fCallBack.constructor == Function) { fCallBack(xhrj); }
                     } else {

                     }
                 }
             };
             xhrj.open('GET', encodeURI(sUrl), bAsync);
             xhrj.send('Null');
         }
     }

     function RndNum(n) {
         var rnd = "";
         for (var i = 0; i < n; i++)
             rnd += Math.floor(Math.random() * 10);
         return rnd;
     }

     function SetNum(item) {
         var url = "//www.scirp.org/journal/senddownloadnum";
         var args = "paperid=" + item;
         url = url + "?" + args + "&rand=" + RndNum(4);
         window.setTimeout("show('" + url + "')", 3000);
     }


     function show(url) {
         var callback = function (xhrj) { }
         ajaxj.get(url, true, callback, "try");
     }


        </script>

        <script type="text/javascript">
            var ajax2 = {//xmlhttp request
                tryList: function () {
                    var xhr2 = null;
                    for (var i = 0; i < arguments.length; i++) {
                        var lambda = arguments[i];
                        try { xhr2 = lambda(); break; } catch (e) { }
                    }
                    return xhr2;
                },
                init: function () {
                    return this.tryList(
                        function () { return new ActiveXObject('MSXML2.XMLHttp.6.0'); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.3.0'); },
                        function () { return new XMLHttpRequest(); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.5.0'); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.4.0'); },
                        function () { return new ActiveXObject('Msxml2.XMLHTTP'); },
                        function () { return new ActiveXObject('MSXML.XMLHttp'); },
                        function () { return new ActiveXObject('Microsoft.XMLHTTP'); }
                        ) || null;
                },
                post: function (sUrl, sArgs, bAsync, fCallBack, errmsg) {
                    var xhr2 = this.init();
                    xhr2.onreadystatechange = function () {
                        if (xhr2.readyState == 4) {
                            if (xhr2.responseText) {
                                if (fCallBack.constructor == Function) { fCallBack(xhr2); }
                            } else {
                                //alert(errmsg);
                            }
                        }
                    };
                    xhr2.open('POST', encodeURI(sUrl), bAsync);
                    xhr2.setRequestHeader('Content-Length', sArgs.length);
                    xhr2.setRequestHeader('Content-Type', 'application/x-www-form-urlencoded');
                    xhr2.send(sArgs);
                },
                get: function (sUrl, bAsync, fCallBack, errmsg) {
                    var xhr2 = this.init();
                    xhr2.onreadystatechange = function () {
                        if (xhr2.readyState == 4) {
                            if (xhr2.responseText) {
                                if (fCallBack.constructor == Function) { fCallBack(xhr2); }
                            } else {
                                alert(errmsg);
                            }
                        }
                    };
                    xhr2.open('GET', encodeURI(sUrl), bAsync);
                    xhr2.send('Null');
                }
            }




            function SetSearchLink(item) {

                var url = "../journal/recordsearchinformation";
                var skid = $(":hidden[id$=HiddenField_SKID]").val();
                var args = "skid=" + skid;
                url = url + "?" + args + "&urllink=" + item;
                window.setTimeout("showSearchUrl('" + url + "')", 300);
            }

            function showSearchUrl(url) {
                var callback2 = function (xhr2) { }

                ajax2.get(url, true, callback2, "try");
            }

        </script>





<meta name="title" content="Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives" />
<meta name="keywords" content="2-Thienoyl Hydrzones,Antioxidant,Anticancer,Cytotoxicity,Antimicrobial Activity" />
<meta name="description" content="Discover the potential of azabicyclic compounds in biological activities. Explore their structural elucidation and stereochemistry through FT-IR, NMR data. Uncover their anti-proliferative, antioxidant, and antimicrobial properties. Learn about the mechanism of action against liver cancer cells and their free radical scavenging activity. Explore their antibacterial and antifungal potential. Further investigations needed for understanding their antioxidant and anticancer effects." />
<meta name="citation_journal_title" content="Open Journal of Medicinal Chemistry" />
<meta name="citation_publisher" content="Scientific Research Publishing" />
<meta name="citation_authors" content="M. Manimaran;A. Ganapathi;T. Balasankar" />
<meta name="citation_author" content="M. Manimaran" />
<meta name="citation_author" content="A. Ganapathi" />
<meta name="citation_author" content="T. Balasankar" />
<meta name="citation_title" content="Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives" />
<meta name="citation_volume" content="5" />
<meta name="citation_date" content="2015-09-30" />
<meta name="citation_year" content="2015" />
<meta name="citation_doi" content="10.4236/ojmc.2015.53004" />
<meta name="citation_issnPrint" content="2164-3121" />
<meta name="citation_issnOnline" content="2164-313X" />
<meta name="citation_abstract" content="To exploit the potential biological activities of azabicyclic based, seven 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone were synthesized. The structural elucidation and stereochemistry of these compound assigned by FT-IR, 1H, 13C and 2D NMR spectral data. The Structural Activity Relationship (SAR) of the target compounds were examined for their in vitro anti-proliferative, antioxidant and antimicrobial activities. The initial screen was treated against human liver cancer cell lines (HepG2) with IC50 values determined by MTT assay. Fluoro substitution at para position of phenyl ring compound 12 showed more antiproliferative activity against HepG2 at half maximum inhibitory concentration (IC50 = 3.76 μg/mL) than other target hydrazones. The mechanism of the antitumor action of active compound 12 was investigated through Hoechst stain 33342 analyses. It indicated that the compound inhibited HepG2 cancer cells proliferation by triggering apoptotic cell death. The Free radical scavenging activity of all synthesized compounds were evaluated with ,  and  radicals. The compounds 11 (IC50 rang 3.78 - 4.31 μg/mL) and 15 (IC50 rang 4.61 - 5.16 μg/mL) were exhibited higher free radical scavenging activity than standard BHT drug. Besides, all the target compounds were screened for their in vitro antibacterial and antifungal activity against a spectrum of microbial organisms by using twofold dilution method. These studies proved that halogen substituted compounds 12, 13 and 14 were showed excellent inhibitory potency at lowest minimum inhibitory concentration (MIC) range of 6.25 - 25.5 μg/mL. Nevertheless, multiple mechanisms regulating the antioxidant and anticancer effects of the hybrid molecules need to be further investigations." />
<meta name="citation_publication_date" content="2015/9/30" />
<meta name="citation_pdf_url" content="https://www.scirp.org/pdf/OJMC_2015093009422941.pdf" />
<meta name="fulltext_pdf" content="https://www.scirp.org/pdf/OJMC_2015093009422941.pdf" />
<meta name="citation_abstract_html_url" content="https://www.scirp.org/journal/paperabs?paperid=60062" />
<meta name="citation_fulltext_html_url" content="https://www.scirp.org/journal/paperinformation?paperid=60062" />
<meta name="fulltext_html" content="https://www.scirp.org/journal/paperinformation?paperid=60062" />
<meta name="citation_xml_url" content="https://www.scirp.org/xml/60062.xml" />
<meta name="fulltext_xml" content="https://www.scirp.org/xml/60062.xml" />
<meta name="citation_issue" content="3" />
<meta name="citation_online_date" content="2015/9/30" />
<meta name="citation_firstpage" content="33" />
<meta name="citation_lastpage" content="47" />

<meta name="dc.title" content="Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives" />

<meta name="dc.creator" content="M. Manimaran" />
<meta name="dc.creator" content="A. Ganapathi" />
<meta name="dc.creator" content="T. Balasankar" /><meta name="dcterms.issued" content="2015-09-30" />
<meta name="dc.description" content="To exploit the potential biological activities of azabicyclic based, seven 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone were synthesized. The structural elucidation and stereochemistry of these compound assigned by FT-IR, 1H, 13C and 2D NMR spectral data. The Structural Activity Relationship (SAR) of the target compounds were examined for their in vitro anti-proliferative, antioxidant and antimicrobial activities. The initial screen was treated against human liver cancer cell lines (HepG2) with IC50 values determined by MTT assay. Fluoro substitution at para position of phenyl ring compound 12 showed more antiproliferative activity against HepG2 at half maximum inhibitory concentration (IC50 = 3.76 μg/mL) than other target hydrazones. The mechanism of the antitumor action of active compound 12 was investigated through Hoechst stain 33342 analyses. It indicated that the compound inhibited HepG2 cancer cells proliferation by triggering apoptotic cell death. The Free radical scavenging activity of all synthesized compounds were evaluated with ,  and  radicals. The compounds 11 (IC50 rang 3.78 - 4.31 μg/mL) and 15 (IC50 rang 4.61 - 5.16 μg/mL) were exhibited higher free radical scavenging activity than standard BHT drug. Besides, all the target compounds were screened for their in vitro antibacterial and antifungal activity against a spectrum of microbial organisms by using twofold dilution method. These studies proved that halogen substituted compounds 12, 13 and 14 were showed excellent inhibitory potency at lowest minimum inhibitory concentration (MIC) range of 6.25 - 25.5 μg/mL. Nevertheless, multiple mechanisms regulating the antioxidant and anticancer effects of the hybrid molecules need to be further investigations." />
<meta name="dc.source" content="Open Journal of Medicinal Chemistry" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="Scientific Research Publishing" />
<meta name="dc.date" content="2015-09-30" />
<meta name="dc.type" content="Article" />
<meta name="dc.identifier" content="doi:10.4236/ojmc.2015.53004" />
<meta name="dc.language" content="en" />
<meta name="dc.issued" content="2015-09-30" />
<meta name="prism.issnPrint" content="2164-3121" />
<meta name="prism.issnOnline" content="2164-313X" />
<meta name="prism.publicationName" content="Open Journal of Medicinal Chemistry" />
<meta name="prism.publicationDate" content="2015-09-30" />
<meta name="prism.volume" content="5" />
<meta name="prism.number" content="3" />
<meta name="prism.section" content="Article" />
<meta name="prism.startingPage" content="33" />
<meta name="prism.doi" content="10.4236/ojmc.2015.53004" />
<meta name="Author" content="Scientific Research Publishing" />
<meta name="dc.rights" scheme="DCTERMS.URI" content="http://creativecommons.org/licenses/by/4.0/" />
<meta name="dc.rights" content="(c) 2015 by author(s) and Scientific Research Publishing Inc." /></head>
<body>
    <form method="post" action="./paperinformation?paperid=60062" id="form1">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />


<script src="/ScriptResource.axd?d=mQBWVXSQvywKG0wBehnziCfcFgrNM4av8J0HgAKchKpJWZgg0r5Xs80ubwoKV7AD4O3M7796UejusG1WTVZtPN-HH1OVRu1qdJQeBwraVdFzAa5uhBZ1xzdJTuUJ8jxsoiOWVycBi-EqnhEbamCkYQaM6illNzJ1XnAiTPTM4lY1&amp;t=2fe674eb" type="text/javascript"></script>
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="D21FCB0F" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" />


        

        




<header>
    <div class="container row clearfix center-block">
        <div class="col-sm-8 col-xs-9 column" style="padding: 10px 0;"><a href="//www.scirp.org" title="SCIRP - An Academic Publisher" target="_blank">
            <img src="../images/SRP_logo.svg" height="50"></a>
        </div>
        <div class="col-sm-3 col-xs-3 column text-center" style="padding: 20px 0;">
            <a href="/journal/openaccess" title="OPEN ACCESS" target="_blank">
                <img src="../images/Open-Access.svg" height="30"></a>
        </div>
        <div class="col-sm-1 col-xs-2 column visible-lg visible-md visible-sm " style="padding: 20px 0;">
            <a href="https://papersubmission.scirp.org/login.jsp" target="_blank" title="Login">
                <button type="button" class="btn btn-default btn-xs" style="font-size: 18px; font-family: Arial, Helvetica, sans-serif; padding: 0 15px; border: #2f2f2f 1px solid; border-radius: 5px; float: right;">Login</button></a>
        </div>
    </div>
</header>


<nav class="navbar navbar-inverse" role="navigation" style="margin-bottom: 10px;">
    <div class="container container-fluid center-block">
        <div class="navbar-header">
            <a href="https://papersubmission.scirp.org/login.jsp" target="_blank" ><button type="button" class="btn btn-xs btn-default navbar-brand visible-xs" style="width: 80px; height: 30px; font-size: 18px; font-family: Arial, Helvetica, sans-serif; margin: 10px; padding: 0 15px; border-radius: 5px;">Login</button></a>
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#example-navbar-collapse">
                <span class="sr-only">切换导航</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
        </div>
        




<div class="collapse navbar-collapse" id="example-navbar-collapse">
    <ul class="nav navbar-nav" style="font-size: 18px;">
        <li><a href="../" target="_top">Home</a></li>
        <li><a href="../journal/articles" target="_top">Articles</a></li>
        <li><a href="../journal/" target="_top">Journals</a></li>
        <li><a href="../book/" target="_top">Books</a></li>
        <li><a href="../news/" target="_top">News</a></li>
        <li><a href="../aboutus/" target="_top">About</a></li>
        <li><a href="../author/" target="_top">Services</a></li>
        <li><a href="//papersubmission.scirp.org/login.jsp?sub=true" target="_blank">Submit</a></li>
    </ul>
</div>


    </div>
</nav>



        <div class="container-fluid link_here" style="margin-bottom: 15px;">
            <div class="row container center-block clearfix" style="padding: 0;">

                <!--页面导航栏-->
                <div class="col-md-7 column" style="padding: 0;">
                    
<ul class="breadcrumb">
        <li><i class="fa fa-home" style="color: #d71318;"></i>&nbsp;&nbsp;<a href="../index">Home</a></li>
        <li><a href="index">Journals</a></li>
        <li class="active">Article</li>
    </ul>

                </div>

                <!--搜索框-->
                <div class="col-md-5 column">
                    <div class="" style="padding: 5px 0;">
                        <div id="UserControl_search_common_Panel2">
	
    <div class="form-inline search2">
        <input name="ctl00$UserControl_search_common$TextBox_searchCode2" type="text" value="Search Title, Keywords, Author, etc." id="UserControl_search_common_TextBox_searchCode2" class="input2" onFocus="return ClearSearchCondition2();" onBlur="return ShowSearchCondition2();" onkeypress="if(event.keyCode==13){document.all.UserControl_search_common_btnSearch2.focus();document.all.UserControl_search_common_btnSearch2.click();   return   false;}" style="height: 28px;" />
        <button class="btn-md btn_or" type="button">
          <input type="submit" name="ctl00$UserControl_search_common$btnSearch2" value=" " id="UserControl_search_common_btnSearch2" style="width:25px; height:25px; background: none; border:none;background-image: url(../Images/search001.png);  " />  
        </button>
        

    </div>

    <script type="text/javascript">
        function ClearSearchCondition2() {
            var text2 = document.getElementById('UserControl_search_common_TextBox_searchCode2').value;
            if (text2 == "Search Title, Keywords, Author, etc.")
            { document.getElementById('UserControl_search_common_TextBox_searchCode2').value = ""; }
        }

        function ShowSearchCondition2() {
            var text2 = document.getElementById('UserControl_search_common_TextBox_searchCode2').value;
                if (text2 == "")
                { document.getElementById('UserControl_search_common_TextBox_searchCode2').value = "Search Title, Keywords, Author, etc."; }
            }


            function checkLog() {

                var keywords = document.getElementById("UserControl_search_common_TextBox_searchCode2").value;  //关键字

            if (trim(keywords) == "") {
                alert('Please enter keywords!');
                return false;
            }

            if (trim(keywords) == "Search Title, Keywords, Author, etc.") {
                alert('Please enter keywords!');
                return false;
            }

            return true;
        }

        //除去左右空格
        function trim(string) {
            return string.replace(/(^\s*)|(\s*$)/g, "");
        }


    </script>

</div>

                    </div>
                </div>

            </div>
        </div>


        <div class="container">
            <div class="row clearfix">

                <div class="col-md-9 column col-md-push-3">
                    <div class="clearfix con_main" style="margin-bottom: 10px; padding-left: 15px; padding-right: 15px;">
                        
       

<div id="JournalInfor_div_nav_journal" class="column up_link1 clearfix" style="padding: 0;">
            <div class="col-md-9 col-sm-8 txt7">
                <a href="journalarticles?journalid=790" title="Open Journal of Medicinal Chemistry">
                    Open Journal of Medicinal Chemistry</a> &gt; <a href="home?issueid=7020#60062">Vol.5 No.3, September 2015</a>
            </div>
            </div>

    <div id="JournalInfor_div_paper" class="articles_main">
            <div class="art_title" style="text-align:left;">
                Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives <span id="JournalInfor_reviewpaper_show" style="color:gray;font-weight:normal;Display:None;">()</span>
            </div>
            
        <div style="float: left; width: 100%; margin-top: 5px; margin-bottom: 10px;">
                <a href='articles?searchcode=M.++Manimaran&searchfield=authors&page=1' target='_blank'>M.  Manimaran</a><sup>1</sup>, <a href='articles?searchcode=A.++Ganapathi&searchfield=authors&page=1' target='_blank'>A.  Ganapathi</a><sup>2*</sup>, <a href='articles?searchcode=T.++Balasankar&searchfield=authors&page=1' target='_blank'>T.  Balasankar</a><sup>2</sup> 
                <br />
                <span id="JournalInfor_div_affs"><sup>1</sup><a href='articles?searchcode=Department+of+Chemistry%2c+Annamalai+University%2c+Annamalai+Nagar%2c+India&searchfield=affs&page=1' target='_blank'>Department of Chemistry, Annamalai University, Annamalai Nagar, India</a>.<br /><sup>2</sup><a href='articles?searchcode=Chemistry+Section%2c+FEAT%2c+Annamalai+University%2c+Annamalai+Nagar%2c+India&searchfield=affs&page=1' target='_blank'>Chemistry Section, FEAT, Annamalai University, Annamalai Nagar, India</a>.<br /></span>
               
                <span id="JournalInfor_showDOI" style="clear: left;"><b>DOI: </b><a href="http://dx.doi.org/10.4236/ojmc.2015.53004"
                    target="_blank" onclick='SetNum(60062)'>10.4236/ojmc.2015.53004</a></span>&nbsp;&nbsp;
                      
                <a href="//www.scirp.org/pdf/OJMC_2015093009422941.pdf" target="_blank" style="font-size: 14px; font-weight: bold;" onclick='SetNum(60062)'>
                    PDF</a>
            &nbsp;&nbsp;&nbsp;<span style="font-size: 14px; font-weight: bold;"><a href='//www.scirp.org/journal/paperinformation?paperid=60062' target='_blank'>HTML</a></span>&nbsp;&nbsp;<span style="font-size: 14px; font-weight: bold;"> <a href='//www.scirp.org/xml/60062.xml' target='_blank' onclick='SetNum(60062)' >XML</a></span>&nbsp;&nbsp;
                <span style="font-weight: bold; color: Red;">
                    4,249</span>
                <span style="color: #535353;">Downloads</span>&nbsp;&nbsp;<span style="font-weight: bold; color: Red;">
                    5,519</span>
                <span style="color: #535353;">Views</span>&nbsp;&nbsp;
                <span id="JournalInfor_span_citations" style="Display:inline;"><a href='papercitationdetails?paperid=60062&JournalID=790' target="_blank"><span style="text-decoration: underline;">Citations</span></a></span>
            </div>

            <div style="margin-bottom: 10px;">
                <p style="font-weight: bold; font-size: 16px;"><a name="abstract" style="color: #2f2f2f;">Abstract</a></p>
                <p style="text-align:left;">To exploit the potential biological activities of azabicyclic based, seven 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone were synthesized. The structural elucidation and stereochemistry of these compound assigned by FT-IR, <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectral data. The Structural Activity Relationship (SAR) of the target compounds were examined for their <i>in vitro</i> anti-proliferative, antioxidant and antimicrobial activities. The initial screen was treated against human liver cancer cell lines (HepG2) with IC<sub>50</sub> values determined by MTT assay. Fluoro substitution at para position of phenyl ring compound 12 showed more antiproliferative activity against HepG2 at half maximum inhibitory concentration (IC<sub>50</sub> = 3.76 μg/mL) than other target hydrazones. The mechanism of the antitumor action of active compound 12 was investigated through Hoechst stain 33342 analyses. It indicated that the compound inhibited HepG2 cancer cells proliferation by triggering apoptotic cell death. The Free radical scavenging activity of all synthesized compounds were evaluated with <img src="//file.scirp.org/image/Edit_93c6f4c8-2935-4a3c-833e-9aea56a04c60.jpg" width="38" alt="" />, <img src="//file.scirp.org/image/Edit_e99385dd-bb24-4b0f-855d-04e38e20617d.jpg" width="25" height="14" alt="" /> and <img src="//file.scirp.org/image/Edit_42717dc4-a3b6-470e-9113-57b42f8bb252.jpg" width="22" height="17" alt="" /> radicals. The compounds 11 (IC<sub>50</sub> rang 3.78 - 4.31 μg/mL) and 15 (IC<sub>50</sub> rang 4.61 - 5.16 μg/mL) were exhibited higher free radical scavenging activity than standard BHT drug. Besides, all the target compounds were screened for their <i>in vitro</i> antibacterial and antifungal activity against a spectrum of microbial organisms by using twofold dilution method. These studies proved that halogen substituted compounds 12, 13 and 14 were showed excellent inhibitory potency at lowest minimum inhibitory concentration (MIC) range of 6.25 - 25.5 μg/mL. Nevertheless, multiple mechanisms regulating the antioxidant and anticancer effects of the hybrid molecules need to be further investigations.</p>
            </div>

            <div id="JournalInfor_div_showkeywords" style="margin-bottom: 10px;">
                <p style="font-weight: bold; font-size: 16px;">Keywords</p>
                <p><a href='articles?searchcode=2-Thienoyl+Hydrzones&searchfield=keyword&page=1' target='_blank'>2-Thienoyl Hydrzones</a>, <a href='articles?searchcode=+Antioxidant&searchfield=keyword&page=1' target='_blank'> Antioxidant</a>, <a href='articles?searchcode=+Anticancer&searchfield=keyword&page=1' target='_blank'> Anticancer</a>, <a href='articles?searchcode=+Cytotoxicity&searchfield=keyword&page=1' target='_blank'> Cytotoxicity</a>, <a href='articles?searchcode=+Antimicrobial+Activity&searchfield=keyword&page=1' target='_blank'> Antimicrobial Activity</a> </p>
            </div>

            <div style="margin-bottom: 10px;">
                <p style="font-size: 16px; font-weight: bold;">Share and Cite: </p>
                <div id="JournalInfor_div_share">   
                  <!-- AddToAny BEGIN -->

<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_sina_weibo"></a>
<a class="a2a_dd" href="https://www.addtoany.com/share"></a>
</div>
<script type="text/javascript" async src="https://static.addtoany.com/menu/page.js"></script>
<!-- AddToAny END -->
                    

                                      
                </div>
                <div style="margin-top: 10px; text-align:left;">
                    Manimaran, M. , Ganapathi, A.  and Balasankar, T.   (2015) Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives. <i>Open Journal of Medicinal Chemistry</i>, <b>5</b>, 33-47. doi: <a href='http://dx.doi.org/10.4236/ojmc.2015.53004' target='_blank' onclick='SetNum(60062)'>10.4236/ojmc.2015.53004</a>.
                </div>
            </div>
            <div style="margin-top:10px;" id="htmlContent">
                 
<p></p>
<p class="E-Title1">1. Introduction</p>
<p>At present, human liver cancer is a major reason for death worldwide. The proportion of people suffering from cancer is estimated to continue growing largely because of the aging of population in most countries [1] . Reactive oxygen, nitrogen and sulphur (NOS) are important for an organism’s vital activities such as the regulation of biological active compounds. Extreme production of reactive oxygen species causes oxidative stress, chronic diseases and cancer. NOS containing molecules are well known to directly interact with all types of biological molecules, proteins, DNA and lipids [2] -[4] . The shared adverse effects are termed oxidative stress. Oxidative stress has involved in the various hallmark abilities of cancer [2] -[4] . Research over the past numerous decades has established that antioxidants play a protective role in multistage carcinogenesis [3] [4] . Generally, a living organism has protective enzymatic and non-enzymatic antioxidant mechanisms against Reactive Oxygen Species (ROS) induced oxidative damage. Recently, significant attention has focused on identifying synthetic antioxidants that aim several signaling pathways are abnormal in cancer.</p>
<p>The 3-azabicyclo [3.3.1] nonane pharmacophore is present in a wide variety of naturally occurring diterphenoid/nor diterphenoid alkaloids and biological activities [5] -[7] . 2, 4-Diaryl-3-azabicyclo [3.3.1] nonan-9-one derivatives are showed excellent antitumor [8] and antimicrobial [9] activities. Correlation between cytotoxicity and antioxidant capacity of natural/synthetic compounds [10] , we are discovered strong cytotoxicity with poor antioxidant properties of synthesized halogen substituted such as F, Cl and Br compounds may be due to the pro-oxidant effects. Although potent antioxidant often possess strong pro-oxidant activity, found low cytotoxicity in synthetic compounds with electron donating functional groups (-CH<sub>3</sub>, -OCH<sub>3</sub> and CH(CH<sub>3</sub>)<sub>2</sub>) present on the aryl rings attached to azabicyclo [3.3.1] nonane-9-ones in line with the observations of Lee et al. [11] Though, multiple mechanisms regulating the antioxidant and cytotoxic effects of the hybrid molecules necessitate to be further investigations.</p>
<p>The half maximum inhibitory concentration (IC<sub>50</sub>) has measured the effectiveness of synthesized compounds in inhibiting specific biological functions of anticancer activity and free radical scavenging activity. This quantitative measurement indicates how much of a particular drug is need to inhibit a given biological microorganisms by half. It is generally used as a measure of antagonist drug potency in pharmacological research work. The IC<sub>50</sub> values of drug (synthesized target compounds) can be determined by constructing a dose response and investigate the effect of different concentrations of antagonist on reversing agonist activity. IC<sub>50</sub> values can be measured for a given antagonist by determining the concentration required to inhibit half of the maximum biological response of the agonist. Hepatocellular carcinoma (HepG2) is derived from the liver tissue of human. This cell lines obtained from National centre for cell sciences (NCCS), Pune, India and it is a best suitable cell lines to evaluate the cytotoxicity of synthesized compounds. The use of electron donating and withdrawing substituent at aromatic compounds with regards to biological activity has established [12] and several interesting investigations are made through piperidine based heterocyclic compounds and exhibited antimicrobial, antioxidant, antithrombic, calcium antagonist, hypotensive and neuroleptic activities [13] - [16] . Hydrazone are noteworthy molecule containing extremely reactive azomethyne (-CONHNC&lt;) are one useful in drug development [17] . 2-Thiophenecarboxylic acid hydrazide has involved significant attention due to the biological activity which has been widely recognized and practically applied in a number of drugs [18] [19] .</p>
<p>In this paper, we report synthesis of seven 2r, (Scheme 1) 4c-Diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’- thienoyl hydrazones highlights the in vitro antioxidant, antitumor and antimicrobial activities against three kinds of free radicals, human liver hepatocellular carcinoma (HepG2) cell lines, bacteria and fungi strain organisms, respectively.</p>
<p class="E-Title1">2. Experimental Methods</p>
<p class="E-Title2">2.1. Chemistry</p>
<p class="E-Title3">2.1.1. Chemicals Equipment Techniques for Structural Elucidation</p>
<p>2-Thiophenecarboxylic acid hydrazide, substituted aldehydes and solvents were purchased from Sigma-Aldrich<sup>&reg;</sup>, Himedia<sup>&reg;</sup> and Merck<sup>&reg;</sup>, Germany, were used directly without further recrystellization. Reaction process and purity were monitored by thin layer chromatography (TLC). Physical properties of melting point were determined in an Electro thermal 9100 instrument in open capillaries and are uncorrected. FT-IR analysis has been recorded in an IR-470 SHIMADZU spectrometer (Shimadzu, Tokyo, Japan.) by making pellet of compound with KBr</p>
<p><img src="//html.scirp.org/file/1-1790084x7.png" class="100" /></p>
<p>Scheme 1. Synthesis of 2r, 4c-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazones (9-15).</p>
<p>and values are expressed as v<sub>max</sub> cm<sup>−1</sup>. <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectra were recorded at ambient temperature on a Bruker AMX-400 NMR spectrometer operating at 400.13MHz for <sup>1</sup>H and 100.62 MHz for <sup>13</sup>C. Chemical shift (δ) unit expressed in parts per million (ppm) with respect to TMS. Sample was prepared in CDCl<sub>3</sub> solvent (10 mg in 0.5 mL). Elemental analysis for all synthesized compounds was performed on an Elementor Vario EL-III CHNS analyzer.</p>
<p class="E-Title3">2.1.2. General Procedure for Synthesized Compound 2r, 4c-Diaryl-3-Azabicyclo [3.3.1] Nonan-9-One-2’-Thienoyl Hydrazones (9-15)</p>
<p>First 2r, 4c-Diaryl-3-azabicyclo [3.3.1]nonan-9-ones (1-7) were prepared by the condensation of appropriate cyclohexanone (1equiv), respective aromatic aldehyde (2equiv) and Ammonium acetate (1.5equiv) dissolved in ethanol was kept in water bath by maintaining the bath temperature at 60˚C - 75˚C with continuous stirring using literature procedure [20] . The crude product precipitated from the solvent was filtered. It was washed through etheric ethanol solution. An ethanol/chloroform/acetone mixture ratio (2:1:1) was used for recrystallization of 1-7 compounds. A mixture of 2r, 4c-Diaryl-3-azabicyclo [3.3.1] nonan-9-one (1 mmol) and 2-Thiophe- necarboxylic acid hydrazide (1.5 mmol) was dissolved in methanol and CHCl<sub>3</sub> (1:1v/v) and few drops of acetic acid was added as catalyst. The reaction mixture was refluxed for 2 - 3 h. On the completion of reaction a solid mass was formed. After the precipitate was filtered at room temperature and washed with cold mixture of water/ethanol mixture. The crude compounds were recrystallized from ethanol.</p>
<p>2r, 4c-Diphenyl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 9</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3034.03, 2924.09, 2854.65 (C-H stretching), 3302.13(-NH-), 1641.42 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.214 (s, 1H, HN-C=O), 4.490 (s, 1H, H-2a), 4.386 (s, 1H, H-4a), 3.342 (s, 1H, H-5e), 2.867 (d, 1H, H-7a), 2.76 (s, 1H, H-1e), 1.885 (s, 2H, H-8e, H-6a), 1.590 (m, 3H, H-8a, H-6e and ring NH) 1.417 (s, 1H, H-7e), 8.166 - 7.135 (m, 13H, aromatic and thienoyl ring protons). <sup>13</sup>C NMR (δppm): 65.47 (C-2), 63.60 (C-4), 46.09 (C-1), 38.48 (C-5), 28.56 (C-8), 27.34 (C-6), 21.56 (C-7), 142.39 (C-2ʹ), 141.31 (C-4ʹ), 163.56 (C-9), 161.81 (HN-C=O), 141.31 - 126.35 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-methylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 10</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3041.74, 2956.87, 2922.16 (C-H stretching), 3307.92 (-NH-), 1633.71 (C=O stretching), 1516.05 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.005 (s, 1H, HN-C=O), 4.476 (s, 1H, H-2a), 4.364 (s, 1H, H-4a), 3.278 (s, 1H, H-5e), 2.901 (s, 1H, H-7a), 2.751 (s, 1H, H-1e), 1.899 (s, 2H, H-8e, H-6a), 1.663 (m, 3H, H-8a, H-6e and ring NH) 1.442 (s, 1H, H-7e), 2.457 (d, 6H, p-<img src="//html.scirp.org/file/1-1790084x8.png" class="200" />, <img src="//html.scirp.org/file/1-1790084x9.png" class="200" /> are merged together) 8.233 - 7.139 (m, 11H, aromatic and thienoyl ring protons). <sup>13</sup>C NMR (δppm): 65.28 (C-2), 63.44 (C-4). 46.16 (C-1), 38.55 (C-5), 28.56 (C-8), 27.34 (C-6), 21.58 (C-7), 144.66 (C-2ʹ), 140.61 (C-4ʹ), 163.44 (C-9), 162.16 (HN-C=O), 21.18 (p-<img src="//html.scirp.org/file/1-1790084x10.png" class="200" /> and <img src="//html.scirp.org/file/1-1790084x11.png" class="200" /> are merged together), 139.00 - 126.34 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-methoxylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 11</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3032.10, 2926.01, 2845 (C-H stretching), 3302.13 (-NH-), 1639.49 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 9.933 (s, 1H, HN-C=O), 4.447 (s, 1H, H-2a), 4.337 (s, 1H, H-4a), 3.231 (s, 1H, H-5e), 2.885 (bs, 1H, H-7a), 2.716 (s, 1H, H-1e), 1.902 (s, 2H, H-8e, H-6a), 1.774 - 1.567 (m, 3H, H-8a, H-6e and ring NH) 1.452 (s, 1H, H-7e), 3.879 (s, 6H, p-<img src="//html.scirp.org/file/1-1790084x12.png" class="200" />, <img src="//html.scirp.org/file/1-1790084x13.png" class="200" /> are merged together) 8.229 - 6.990 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 65.02 (C-2), 63.18 (C-4). 46.23 (C-1), 38.62 (C-5), 28.51 (C-8), 27.05 (C-6), 21.60 (C-7), 144.73 (C-2ʹ), 144.40 (C-4ʹ), 163.47 (C-9), 158.97 (HN-C=O), 55.42 (p-<img src="//html.scirp.org/file/1-1790084x14.png" class="200" />, <img src="//html.scirp.org/file/1-1790084x15.png" class="200" /> are merged together), 135.39 - 113.80 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-fluorophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 12</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3024.38, 2920.23, 2848.86 (C-H stretching), 3300.20 (-NH-), 1633.71 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.311 (s, 1H, HN-C=O), 4.437 (t, 2H, H-2a and H-4a are merged together), 3.283 (s, 1H, H-5e), 2.849 (d, 1H, H-7a), 2.737 (s, 1H, H-1e), 1.915 (d, 2H, H-8e, H-6a), 1.758 - 1.676 (m, 3H, H-8a, H-6e and ring NH), 1.462 (d, 1H, H-7e), 8.244 - 7.144 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.14 (C-2), 62.97 (C-4), 46.04 (C-1), 38.38 (C-5), 28.94 (C-8), 27.05 (C-6), 21.11 (C-7), 143.38 (C-2ʹ), 141.40 (C-4ʹ), 163.43 (C-9), 160.99 (HN-C=O), 136.34 - 115.25 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-chlorophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 13</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3041.74, 2924.09, 2854.65 (C-H stretching), 3309.85 (-NH-), 1633.71 (C=O stretching), 1485.19 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm):10.579 (s, 1H, HN-C=O), 4.489 (s, 1H, H-2a), 4.419 (d, 1H, H-4a), 3.437 (s, 1H, H-5e), 2.779 (d, 2H, H-7a and H-1e are merged together), 1.904 - 1.596 (m, 5H, H-8e, H-6a, H-8a, H-6e and ring NH), 1.447 (s, 1H, H-7e), 8.20 - 7.202 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.12 (C-2), 62.86 (C-4), 45.85 (C-1), 38.25 (C-5), 28.95 (C-8), 27.21 (C-6), 21.43 (C-7), 143.34 (C-2ʹ), 140.66 (C-4ʹ), 164.01 (C-9), 161.51 (HN-C=O), 140.30 - 126.42 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-bromophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 14</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3039.81, 2966.52, 2922.16 and 2854.65 (C-H stretching), 3300.20 (-NH-), 1639.49 (C=O stretching), 1512.19 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.519 (s, 1H, HN-C=O), 4.465 (s, 1H, H-2a), 4.395 (s, 1H, H-4a), 3.471 (s, 1H, H-5e), 2.798 (m, 2H, H-7a, H-1e are merged together), 1.905 - 1.759 (m, 5H, H-8e, H-6a, H-8a, H-6e and ring NH are merged together), 1.441 (s, 1H, H-7e), 8.229 - 7.206 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.16 (C-2), 62.92 (C-4), 42.78 (C-1), 38.20 (C-5), 28.95 (C-8), 27.04 (C-6), 21.42 (C-7), 140.75 (C-2ʹ), 140.04 (C-4ʹ), 164.58 (C-9), 163.31 (HN-C=O), 134.80 - 121.23 (aromatic and thienoyl ring carbons).</p>
<p>2r, 4c-Bis (p-isopropylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 15</p>
<p>IR (KBr) (cm<sup>−1</sup>): 3026.31, 2958.80, 2864.29, 2926.01 (C-H stretching), 3304.06 (-NH-), 1635.64 (C=O stretching), 1514.12 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.625 (s, 1H, HN-C=O), 4.505 (s, 1H, H-2a), 4.419 (d, 1H, H-4a), 3.472 (s, 1H, H-5e), 2.990 (d, 3H, H-7a and p-isopropyl <img src="//html.scirp.org/file/1-1790084x16.png" class="200" /> &amp;<img src="//html.scirp.org/file/1-1790084x17.png" class="200" />), 2.789 (s, 1H, H-1e), 1.977 (d, 2H, H-8e, H-6a), 1.716 - 1.594 (m, 3H, H-8a, H-6e and ring NH) 1.449 (d, 1H, H-7e), 1.337 (d,12H, p-isopropyl <img src="//html.scirp.org/file/1-1790084x18.png" class="200" />&amp; <img src="//html.scirp.org/file/1-1790084x19.png" class="200" /> 8.229 - 7.182 (m, 11H, aromatic and thienoylring protons).<sup> 13</sup>C NMR (δppm): 64.69 (C-2), 63.40 (C-4). 46.15 (C-1), 38.59 (C-5), 28.70 (C-8), 27.06 (C-6), 21.61 (C-7), 148.19 (C-2ʹ), 147.95 (C-4ʹ), 163.84 (C-9) , 162.63 (HN-C=O), 24.19 - 23.86 (p-isopropyl<img src="//html.scirp.org/file/1-1790084x20.png" class="200" />, <img src="//html.scirp.org/file/1-1790084x21.png" class="200" />,<img class="200" data-original="//html.scirp.org/file/1-1790084x23.png" /><img class="200" data-original="//html.scirp.org/file/1-1790084x22.png" />), 34.05 (p-isopropyl <img class="200" data-original="//html.scirp.org/file/1-1790084x24.png" /><sup> </sup>&amp;<img class="200" data-original="//html.scirp.org/file/1-1790084x25.png" />), 139.96 - 126.23 (aromatic and thienoylring carbons).</p>
<p class="E-Title2">2.2. Pharmacology</p>
<p class="E-Title3">2.2.1. In Vitro Antioxidant Activity</p>
<p>The antioxidant capacity was measured by the 2, 2-Diphenyl-1-picrylhydrazyl (DPPH<sup>•</sup>) explained by Blois [21] . Hydroxyl radical (OH<sup>•</sup>) scavenging capacity was described by the method of Ren et al., (2008) [22] on the basis of the ability to complete with deoxyribose for OH<sup>•</sup>. Superoxide anions resulting from dissolved oxygen by a PMS/NADH coupling reaction reduced nitro blue tetrazolin (NBT) was evaluated by the procedure of Garrat et al. (1964) [23] . Scavenging capacity carried out triplicate of each sample and read at 515 nm using a micro plate reader (EL-800 Bio Tac instrument, Winoski, VT, USA). The percentage of scavenging assay DPPH<sup>•</sup>, OH<sup>•</sup> and <img class="200" data-original="//html.scirp.org/file/1-1790084x26.png" /> was calculated using the following formula</p>
<p>Free radical scavenging activity (%) = <img class="200" data-original="//html.scirp.org/file/1-1790084x27.png" /></p>
<p>where Ac is the absorbance of control and As is absorbance of sample. BHT (Butylated hydroxytoluene) was used as standard drug. Which was calculated based on its concentration of compound required to reduce free radicals by 50% (IC<sub>50</sub>) as follows.</p>
<p class="E-Title3">2.2.2. Cell Culture and Preservation</p>
<p>Human liver cancer cell lines (HepG2) were obtained from the National centre for cell sciences (NCCS). Pune, India. The cells cultivated in 0.5 mg MTT (3, [4, 5-dimethythiazole-2-yl] 2, 5-diphenyl tetrazolium bromide)/ML. of serum free DMEM (Dulbecco’s modified Eagle’s medium) at 37˚C with 5% CO<sub>2</sub> and 95% air in a CO<sub>2</sub> incubator. The viability of cells was measured by MTT assay (Mosmann, 1983) [24] using the HepG2 cell lines. The cell lines were treated with various concentrations of test compounds (3.12, 6.25, 12.50, 25 and 50 &micro;g/mL) for 24 h. The 50% inhibitory concentration values (IC<sub>50</sub>) of all experiments of test compounds were done using three replicates. Cytotoxicity was detected by using Graph pad prism 5 software.</p>
<p class="E-Title3">2.2.3. Apoptosis Detection of Nuclear Morphology</p>
<p>Cells were stained with 0.5 mL of Hoechst 33342 solution (3.5 &micro;g/mL) and incubated for 30 min at 37˚C incubator. The Hoechst dyes can also be obtained from molecular probs. H342 is a “vital” DNA stain that binds preferentially to A-T base pains. Cells should be approximately 1.2 &times; 10<sup>6</sup> mL in buffered media, pH 7.2. It is also useful to include 2 percent fetal half cell serum (FCS) to maintain the cell, and measured by fluorescence microscope at 490 - 520 nm [25] . Apoptotic cell were defined on the mass of nuclear morphology changes such as chromatin condensation and fragmentation. Early apoptotic cells show navy blue fluorescence.</p>
<p class="E-Title3">2.2.4. In Vitro Antibacterial and Antifungal Activity</p>
<p>Minimum inhibitory concentration (MIC) in &micro;g/mL values were found out by two-fold serial dilution method [26] . Bacterial strain namely Staphylococcus aureus. Escherichia coli, Klebsiella pheumoniae, pseudomonas aeruginosa and Salmonella typhi and fungal strain namely Cryptococcus neoformans, Candida albicans, Rizopus sp, Aspergillus nigar and Aspergillus flavus, were obtained from Faculty of medicine, Annamalai University, Annamalai Nagar, 608002, India. Seeded broth (broth containing microbial sporus) was prepared in NB from 24 hours old bacterial cultures on nutrient ager (Himedia, Mumbai) at 37˚C while fungal strains were cultures in sabourauds dextrose broth (SDB). Testing was performed at pH 7.4 &plusmn; 0.2 for bacteria (NB) and at a pH 5.6 for fungi (SDB). Plating techniques were used to determine the colony forming units (cfu) of the seeded broth in the adjusted range of 10<sup>4</sup> to 10<sup>5</sup> cfu/mL and 1.1 to 1.5 &times; 10<sup>2</sup> cfu/mL were the final inoculums size for antibacterial and antifungal assay, respectively. The respective test compounds 9-15 were dissolved in dimethyl sulphoxide (DMSO) to obtain 1 mg/mL stock solution. The growth of the microbes in the test medium was measured on the turbidity of the culture after 24 hours of bacterial incubation and 72 - 96 hours of fungal incubation.</p>
<p class="E-Title3">2.2.5. Statistical Analysis<sup> </sup></p>
<p>All investigated data were presented as the percentage of Mean &plusmn; SEM (standard error of mean) of at least three individual experiments. Statistical analysis was performed with One-way ANOVA test analysis using the prism 5 statistical software package (graph pad software. USA). Differences were considered as being significant probability at p &lt; 0.005.<sup> </sup></p>
<p class="E-Title1">3. Results and Discussion</p>
<p class="E-Title2">3.1. Chemistry</p>
<p>The structural elucidation and stereochemistry of target compounds 9-15 were assigned by IR and NMR spectral data. Their purities were checked by elemental analysis <a href="#t1" target="_self">Table 1</a>. For compound 9, proton NMR <sup>1</sup>H and<sup>13</sup>C NMR signal were assigned unambiguously using two-dimensional spectra.</p>
<p class="E-Title2">3.2. Numbering of Atoms</p>
<p><a href="#f1" target="_self">Figure 1</a> shows the numbering pattern of the bicyclo [3.3.1] nonane part. The ipso carbons of the phenyl rings at C-2 and C-4 are designated as C-2&quot; and C-4&quot;, respectively. The other carbons of the phenyl ring at C-2 are denoted also o, m and p carbons and those of the phenyl ring at C-4 were denoted as oʹ, mʹ, pʹ, carbons. Protons are numbered accordingly. Thiophene ring sulpfur atom was denoted as 1’. For illustrated, the benzyl proton at C-2 was denoted as H-2, C-4 was denoted as H-4 and so on. The methylene protons in the cyclohexane ring are</p> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_1-1790084_1.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t1" id="t1"><span class="cs_fig_con">Table 1</span></a>. Elemental analytical data of titled compound 9-15.</p>
</div>
<p><sup>*</sup>The measured values for C, H, N and S were within &plusmn;0.4% of the theoretical values.</p>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x28.png" /></p>
 <p class=" sacImgMarkCss"><a name="f1" id="f1"><span class="cs_fig_con">Figure 1</span></a>. Numbering of the atoms.</p>
</div>
<p>assigned as axial and equatorial protons assuming chair conformation for the cyclohexanone ring. C-7 protons are denoted as H-7a and H-7e.</p>
<p class="E-Title2">3.3. IR Spectral Analysis</p>
<p>Hydrazones formation were assigned by C=N stretching frequency at present in the range of 1485 - 1516 cm<sup>−1</sup>. The bicyclic NH stretching frequency was in the range 3300 - 3309 cm<sup>−1</sup> and the amide (C=O) stretching frequency was in the range 1633 - 1641 cm<sup>−1</sup>. The amide NH stretching frequency was in the range 3024 - 3163 cm<sup>−1</sup>, the adsorption band in the region of 2845 - 3041 cm<sup>−1</sup> were attributed to aromatic, thienoyl ring and aliphatic C-H stretching frequencies [8] .</p>
<p class="E-Title2">3.4. <sup>1</sup>H NMR Spectral Analysis</p>
<p>For compound 9 the <sup>1</sup>H NMR signals were unambiguously assigned based on the observed correlation in the two dimensional (2D) NMR spectra. A broad and down field singlet at 10.21 ppm was characteristic of the NH amide group. Signal broadening is due to the faster exchange of NH proton with solvent moisture than the resonance time scale. NH proton of the bicyclic ring and H-8a &amp; H-6e protons were merged together and appeared as multiplets at 1.59 ppm. However, signal that appeared at 2.76 and 3.34 ppm should be due to its bridgehead protons H-1e and H-5e, respectively. Two signals appeared at 4.49 and 4.39 ppm corresponds to each one proton integral. Furthermore, these two signal strong NOE shown in <a href="#f2" target="_self">Figure 2</a>, with doublet at 7.64 ppm and singlet at 2.76 &amp; 3.34 ppm. Hence unambiguity, these two signals are attributed to benzylic protons H-2a and H-4a. However, peaks at 2.76 and 3.34 ppm have been weak COSY correlation <a href="#f3" target="_self">Figure 3</a> with benzylic protons and strong correlation with H-6a (1.88 ppm) and H-8a (1.59 ppm). H-1e and H-5e signal, one was highly deshielded</p>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x29.png" /></p>
 <p class=" sacImgMarkCss"><a name="f2" id="f2"><span class="cs_fig_con">Figure 2</span></a>. NOESY Spectrum of compound 9.</p>
</div>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x30.png" /></p>
 <p class=" sacImgMarkCss"><a name="f3" id="f3"><span class="cs_fig_con">Figure 3</span></a>. <sup>1</sup>H-<sup>1</sup>H COSY and NOESY correlations of compound 9.</p>
</div>
<p>due to special interaction between the nitrogen (&gt;CONH-) of thienoyl hydrazone analogue and one of the bridgehead proton. Outstanding to this interaction, partial charges created between them [27] . As a result, the bridge head α-carbon acquires slight negative (-ve) charge and the attached proton gets slight (+ve) charge as shown in <a href="#f4" target="_self">Figure 4</a>. From this, the deshielded signal can be unambiguously assigned to syn α(H-5) bridgehead proton whereas shielded signal was assigned to anti α(H-1) proton.</p>
<p>Among the two observed signal 1.59 ppm and 1.88 ppm were deshielded signal assigned to H-6e and H-8e protons and the shielded one was assigned to H-6a and H-8a protons. Furthermore, the signals for C-7 protons were magnetically nonequivalent and observed at 2.87 and 1.41 ppm respectively for H-7a and H7e. H-7a proton were deshielded due to deshieding creates vanderwaals interaction. Therefore H-7a proton was highly deshielded than H-7e proton <sup>1</sup>H-<sup>1</sup>H COSY correlation chemical shift of compound 9 shown in <a href="#f5" target="_self">Figure 5</a>, H-2 and H-4 proton have also shown a cross peak with doublet at 7.64 ppm which suggest that the signal have four protons integral is due to ortho protons of phenyl ring. All the aromatic and thienoyl ring protons which were collectively resonate between 7.13 to 8.16 ppm. All these surveillance were consistent with twin-chair (CC) conformation for this compound 9. For all other target compounds the <sup>1</sup>H signal were assigned by comparison with compound 9.</p>
<p class="E-Title2">3.5. <sup>13</sup>C NMR Spectral Analysis</p>
<p>In <sup>13</sup>C NMR spectral of synthesized compound 9, two downfield signals 163.56 and 161.81 ppm were assigned for C=N and C=O carbons, respectively. However, there were two resonance carbon signals at 65.47 and 63.60 ppm is respectively due to C-2 and C-4 carbons. Furthermore, the carbon concerned in the fusion part C-5 and C-1 were consigned from the downfield signal at 38.41 and 46.09 ppm, respectively. The methylene carbons signal C-6, C-7 and C-8 of cyclohexanone were assigned in the region of 27.34, 21.56, and 28.56 ppm, respectively. Aromatic, ipso and thienoyl hydrazone carbons were assigned with admiration to their <sup>1</sup>H-<sup>13</sup>C COSY (HSQC) correlations shown in <a href="#f6" target="_self">Figure 6</a>. Assignments for the other synthesized compounds 10-15 were made by comparison with compound 9. X-ray crystallographic study established that 2r, 4c-diphenyl-9t-ethynyl-3-aza- bicyclo [3.3.1] nonan-9t-ol exists in twin chair conformation with equatorial orientations of the aryl groups [28] .</p>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x31.png" /></p>
 <p class=" sacImgMarkCss"><a name="f4" id="f4"><span class="cs_fig_con">Figure 4</span></a>. Non-bonded interaction between H-5e and nitrogen (thienoyl hydrazone NHCO).</p>
</div>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x32.png" /></p>
 <p class=" sacImgMarkCss"><a name="f5" id="f5"><span class="cs_fig_con">Figure 5</span></a>. <sup>1</sup>H-<sup>1</sup>H COSY Spectrum of compound 9.</p>
</div>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x33.png" /></p>
 <p class=" sacImgMarkCss"><a name="f6" id="f6"><span class="cs_fig_con">Figure 6</span></a>. HSQC Spectrum of compound 9.</p>
</div>
<p>Taken together, all of the above observations substantiate planned structure and twin-chair (CC) conformation of 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2-thienoyl hydrazones (9-15).</p>
<p class="E-Title2">3.6. In Vitro Free Radical Scavenging Activity</p>
<p>Seven various 2-thienoyl hydrazone derivatives 9-15 were examined for their in vitro antioxidant activity against DPPH<sup>•</sup>, OH<sup>•</sup> and <img class="200" data-original="//html.scirp.org/file/1-1790084x34.png" /> radicals. 50 percent (50%) inhibitory concentration (IC<sub>50</sub>) values for the free radical scavenging effect of BHT and various substituted synthetic compounds 9-15 were shown in <a href="#t2" target="_self">Table 2</a>. Free radical scavenging activity was treated with different concentration level 3.12, 6.25, 12.5, 25 and 50 &micro;g/mL. We reported that electron-donor methoxy (OCH<sub>3</sub>) substitution compound 11 (IC<sub>50</sub> range 3.78 - 4.31 &micro;g/mL) showed excellent antioxidant capacity compared to other compounds and standard antioxidant, a known antioxidant used as a positive control shown in <a href="#f7" target="_self">Figure 7</a>. Tested with compound 9 devoid of any substituent at phenyl ring at C-2 and C-4 positions of the azabicyclo [3.3.1] nonan-9-one inhibited 50% of the different free radicals at the concentration range 34.26 - 35.65 &micro;g/mL. Compound possessing electron withdrawing fluoro, chloro and bromo substitutions at the phenyl rings showed admirable in-vitro free radical scavenging effect against DPPH<sup>•</sup>, OH<sup>•</sup> and <img class="200" data-original="//html.scirp.org/file/1-1790084x35.png" /> radicals. Therefore, antioxidant capacity of all the synthesized compounds were in the decreasing order 11 &gt; 15 &gt; 10 &gt; 9 &gt; 14 &gt; 13 &gt; 12.</p>
<p class="E-Title2">3.7. In Vitro Anticancer Activity</p>
<p>Human liver cancers foremost reason for human death and malignancy throughout the world, according to survey 7.6 million death in 2010 century and anticipated to reach the figure of almost 13 million death by 2030 century, about 70% cancers [29] [30] . The aim of present work challenged cytotoxic activity against on a panel of human liver hapatocellular carcinoma (HepG2) [31] was treated with the innovative target compound 9-15 significantly inhibited the proliferation of cancer cell lines in various concentrations manner (3.12, 6.25, 12.5, 25</p> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_1-1790084_2.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t2" id="t2"><span class="cs_fig_con">Table 2</span></a>. Inhibitory concentration values (IC<sub>50</sub>) for anti-oxidant activity of compound 9-15.</p>
</div>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x37.png" /></p>
 <p class=" sacImgMarkCss"><a name="f7" id="f7"><span class="cs_fig_con">Figure 7</span></a>. Antioxidant activity of standard (BHT) drug and synthesized compounds 9-15.</p>
</div>
<p>and 50 &micro;g/mL.), after 24 hours of incubation were examined by means of the MTT assay. IC<sub>50</sub> values for the cytotoxic effect of synthetic compounds were shown in <a href="#t3" target="_self">Table 3</a>. The incorporation of electron withdrawing group such as F, Cl and Br substitution at para position of C-2, C-4 diaryl rings of the 3-azabycyclo [3.3.1] nonan-9-one compounds 12, 13 and 14 exhibit more cytotoxicity than electron donating group such as CH<sub>3</sub>, OCH<sub>3</sub> and CH (CH<sub>3</sub>)<sub>2</sub> substitution at para position of C-2, C-4 diaryl rings of the 3-azabycyclo [3.3.1] nonan-9-one compounds 10, 11 and 15. Especially the compound 12 (IC<sub>50</sub> = 3.76 &micro;g/mL) shows excellent cytotoxicity than compounds 13 and 14. We found the strong cytotoxicity with poor antioxidant property of synthesized compounds 12, 13 and 14 may be due to the pro-oxidant effect by halogens [11] . The overall cytotoxicity effect of synthesized compounds were in the decreasing order 12 &gt; 13 &gt; 14 &gt; 11 &gt; 15 &gt; 10 &gt; 9. However several mechanisms regulating the antioxidant and anticancer activity of hybrid molecule are needed for advance research.</p>
<p class="E-Title2">3.8. Discovery of Apoptosis by Hoechst Staining</p>
<p>In treated and controlled cells, apoptosis in nuclear morphology by using Hoechst 33342 (H342) were experiential and compared in the <a href="#f8" target="_self">Figure 8</a>. Fluorescence microscopy analysis was used to assess the apoptotic feature in HepG2 cancer cells induced by fluoro substituted compound 12. The control showed normal health and whole nuclei without any cytomorphological abnormalities. The HepG2 cell lines were treated with 50% inhibitory</p> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_1-1790084_3.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t3" id="t3"><span class="cs_fig_con">Table 3</span></a>. Anticancer activity of target compounds (9-15) against human liver hepatocellular carcinoma cell lines (HepG2).</p>
</div>
<p><sup>b</sup>Values are expressed as the mean &plusmn; SE (standard error) from at least three independent experiments. IC<sub>50</sub>: Compound concentration required to inhibit cancer cells proliferation by 50%.</p>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/1-1790084x38.png" /></p>
 <p class=" sacImgMarkCss"><a name="f8" id="f8"><span class="cs_fig_con">Figure 8</span></a>. The effect of fluorescent microscope image of (a) control (b) the cell treated HepG2 cell lines with IC<sub>50</sub> concentration 3.76 &micro;g/mL of the most active lead compound 12. Stained with Hoechst 33342 (H342). These cell lines detected by 490 - 520 nm of fluorescent microscope excitation/emission.</p>
</div>
<p>concentration among the efficient cytotoxic compound 12 and IC<sub>50</sub> value is 3.76 &micro;g/mL for 48 hours. The dark blue (navy blue) fluorescence indicated the viable cells while the bluish white fluorescence indicated the death cells. The above results of 490 - 520 nm of fluorescence microscopy using Hoechst stain control <a href="#f8" target="_self">Figure 8</a>(a) and treated HepG2 cell lines <a href="#f8" target="_self">Figure 8</a>(b). Bright condensed chromatin (pyknosis) and cell shrinkage was observed in these compound treated apoptotic cells. The report of the procedure, disintegration of the nucleus was also observed in the treated cell lines.</p>
<p class="E-Title2">3.9. In Vitro Antimicrobial Activity</p>
<p>The in vitro antibacterial activity of synthesized compounds 9-15 were treated with bacterial strains viz., (S. aureus. E. coli, K. pheumoniae, p. aeruginosa and S. typhi) and were expressed as minimum inhibitory concentrations (MIC) in &micro;g/mL. Streptomycin was taken as standard drug [32] and the observed MIC values were given in <a href="#t4" target="_self">Table 4</a> Compound 12, 13 and 14 possessing para halo substitution at phenyl rings of azabicyclononane derivatives account for the superior inhibitory effect against S. aureus, K. pheumoniae and S. typhi at MIC values of 6.25 &micro;g/mL, and p. aeruginosa at MIC values of 12.50 &micro;g/mL when compared to standard antibiotic streptomycin. Evidenced that electron withdrawing group substituted azabicyclononane derivatives exhibited marvelous antimicrobial activities [33] . Other target compound displayed reduced inhibitory effect against different bacterial strains compared to standard drug. The account of the present study also provide proof for the antifungal</p> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_1-1790084_4.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t4" id="t4"><span class="cs_fig_con">Table 4</span></a>. In vitro antimicrobial screening of target compounds 9-15.</p>
</div>
<p><sup>*</sup>Standard drug used: for antibacterial activity―Streptomycin, for antifungal activity―Amphotericin B.</p>
<p>effect of an array of 2-thienoyl hydrazones 9-15 with MIC values shown in the <a href="#t4" target="_self">Table 4</a>. Compound 12, 13 and 14 had enhanced inhibitory effect against all tested fungi strains and standard drug (Amphotericin B) of MIC range was 6.25 - 12.5 &micro;g/mL, and isopropyl substituted compound 15 exhibited identical potency compared to standard drug except C. neoformans strain. Other compounds exhibited mild inhibitory potency against different fungi strains compared to standard drug.</p>
<p class="E-Title1">4. Conclusion</p>
<p>The report of the present study of 2-thienoyl hydrazones of 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-ones in excellent yield, stereochemistry and characterized by elemental analysis and spectral data 1D and 2D NMR spectra. All of the above observations substantiate the proposed structure and twin-chair (CC) conformation of all target compounds 9-15. The compounds were evaluated various biological activities. Through the target compound with electron withdrawing such as F, Cl, Br substitution compounds were superior anticancer, antibacterial and antifungal activity. However, the electron donating substituted such as CH<sub>3</sub>, OCH<sub>3</sub> and CH(CH<sub>3</sub>)<sub>2</sub> compounds act great antioxidant activity than electron withdrawing substituted compounds. Studies on the structural mechanisms by which the new synthetic molecules put forth its anticancer, antioxidant, antibacterial and antifungal activity are making development and will be delivered in the prospect.</p>
<p class="E-Title1">Acknowledgements</p>
<p>The authors were great thankful to The Department of Chemistry, Annamalai University, Tamilnadu, India, for the recording of the NMR spectral data’s and providing all necessary facilities to found the present work successfully. We extend our gratitude to the RMMCH, Annamalai University for biological studies.</p>
<p class="E-Title1">NOTES</p>
<p><sup>*</sup>Corresponding author.</p>
            </div>

        
         

            <div style="margin-top: 10px;">
                <p style="font-size: 16px; font-weight: bold;">Conflicts of Interest</p>
                <p style="text-align: justify;">The authors declare no conflicts of interest.</p>
            </div>
     

            <div style="margin-top: 10px;">
                <p style="font-size: 16px; font-weight: bold;">
                    <a name="reference" style="color: #2f2f2f;">References</a>
                </p>
                <p>
                    <table width="100%" border="0" cellspacing="0" cellpadding="0" style="text-align: left; word-break: break-word; ">
                        
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577955' target='_blank'>1</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref1" id="ref1"></a>
                                        (2013) Cancer. Fact Sheet No. 297, World Health Organization, Geneva. 
<br/>http://www.who.int/mediacentre/factsheets/fs297/en/.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577956' target='_blank'>2</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref2" id="ref2"></a>
                                        Poljsak, B., Suput, D. and Milisav, I. (2013) Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 956792. 
http://dx.doi.org/10.1155/2013/956792
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577957' target='_blank'>3</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref3" id="ref3"></a>
                                        Valko, M., Leibfritz, D., Moncol, J., et al. (2007) Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease. International Journal of Biochemistry & Cell Biology, 39, 44-84. 
<br/>http://dx.doi.org/10.1016/j.biocel.2006.07.001
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577958' target='_blank'>4</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref4" id="ref4"></a>
                                        Kasai, H. and Kawai, K. (2006) Oxidative DNA Damage: Mechanisms and Significance in Health and Disease. Antioxidants & Redox Signaling, 8, 981-983. http://dx.doi.org/10.1089/ars.2006.8.981
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577959' target='_blank'>5</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref5" id="ref5"></a>
                                        Jayaraman, P. and Avila, S. (1981) Chemistry of 3-Azabicyclo [3.3.1] Nonanes. Chemical Reviews, 81, 149-174. 
http://dx.doi.org/10.1021/cr00042a002
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577960' target='_blank'>6</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref6" id="ref6"></a>
                                        Hardick, D.I., Balagbrough, I.S., Cooper, G., Potter, B.V.L., Critchley, T. and Wonnacott, S. (1996) Nudicauline and Elatine as Potent Norditerpenoid Ligands at Rat Neuronal a-Bungarotoxin Binding Sites: Importance of the 2-(Methyl- succinimido)benzoyl Moiety for Neuronal Nicotinic Acetylcholine Receptor Binding. Journal of Medicinal Chemistry, 39, 4860-4866. <br/>http://dx.doi.org/10.1021/jm9604991
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577961' target='_blank'>7</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref7" id="ref7"></a>
                                        Barker, D., Lin, D.H.S., Crland, J.E., Chu, C.P.Y., Chebib, M., Brimble, M.A., Savage, C.P. and Mclead, M.D. (2005) Methyllycaconitine Analogues Have Mixed Antagonist Effects at Nicotinic Acetylcholine Receptors. Bioorganic & Medicinal Chemistry, 13, 4565-4575. <br/>http://dx.doi.org/10.1016/j.bmc.2005.04.054
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577962' target='_blank'>8</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref8" id="ref8"></a>
                                        Sankar, C. and Pandiarajan, K. (2010) Synthesis and Anti-Tubercular and Antimicrobial Activities of Some 2r, 4c-diaryl- 3-azabicyclo[3.3.1] Nonan-9-One N-Isonicotinoylhydrazone Derivatives. European Journal of Medicinal Chemistry, 46, 5480-5485. http://dx.doi.org/10.1016/j.ejmech.2010.08.024
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577963' target='_blank'>9</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref9" id="ref9"></a>
                                        Ramachandran, R., Rani, M. and Kabilan, S. (2010) Synthesis, Structure and Conformational Analysis of 2,4-Diaryl-3- Azabicyclo[3.3.1]nonan-9-One Thiosemicarbazones and Semicarbazones. Journal of Molecular Structure, 970, 42-50. 
http://dx.doi.org/10.1016/j.molstruc.2010.02.005
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577964' target='_blank'>10</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref10" id="ref10"></a>
                                        Khaledi, H., Alhadi, A.A., Yehye, W.A., Ali, H.M., Abdulla, M.A. and Hassandarvish, P. (2011) Antioxidant, Cytotoxic Activities, and Structure-Activity Relationship of Gallic Acid-Based Indole Derivatives. Archiv der Pharmazie, 344, 703-709. http://dx.doi.org/10.1002/ardp.201000223
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577965' target='_blank'>11</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref11" id="ref11"></a>
                                        Lee, C.Y., Sharma, A., Uzarski, R.L., Cheong, J.E., Xu, H., Held, R.A., Upadhaya, S.K. and Nelson, J.L. (2011) Potent Antioxidant Dendrimers Lacking Pro-Oxidant Activity. Free Radical Biology and Medicine, 50, 918-925. 
http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.699
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577966' target='_blank'>12</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref12" id="ref12"></a>
                                        Chitra, S., Devanathan, D. and Pandiarajan, K. (2010) Synthesis and in Vitro Microbiological Evaluation of Novel 4-Aryl-5-Isopropoxycarbonyl-6-Methyl-3,4-Dihydropyrimidinones. European Journal of Medicinal Chemistry, 45, 367-371. http://dx.doi.org/10.1016/j.ejmech.2009.09.018
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577967' target='_blank'>13</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref13" id="ref13"></a>
                                        Rossi, C., Figini, A. and Corpi, A. (1968) Antiarrhythmic Action of Certain 1,5-Diphenyl-Bispidin Derivatives. Annali dell’Istituto Superiore di Sanità, 4, 333. (1969) Chemical Abstracts Service, 70, 85997s.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577968' target='_blank'>14</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref14" id="ref14"></a>
                                        Chivarelli, S., Delcarmine, R. and Michalek, H. (1972) Effect of Some Antiarrhythmic 1,5-Diphenyl-Bispidine Derivatives on in Vitro Oxygen Uptake and Glucose Utilization of Rat Heart Muscle. Annali dell’Istituto Superiore di Sanità, 8, 156. (1973) Chemical Abstracts Service, 78, 24098z.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577969' target='_blank'>15</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref15" id="ref15"></a>
                                        Binning, F., Friedrich, L., Hofmann, H.P., Kreiskoh, H., Raschack, M. and Muller, C. (1978) Neue Bispidinderivate, verfahren Zu deren Herstellung und Arzneimittel, Welche diese enthalten. German Patent No. 2726571. (1979) Chemical Abstracts Service, 90, 121568h.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577970' target='_blank'>16</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref16" id="ref16"></a>
                                        a) Ganellin, C.R. and Spickett, R.G.W. (1965) Compounds Affecting the Central Nervous System. I. 4-Piperidones and Related Compounds. Journal of Medicinal Chemistry, 8, 619-625. <br/>http://dx.doi.org/10.1021/jm00329a015
<br/>b) El-Subbagh, H.I., Abu-Zaid, S.M., Mahran, M.A., Badria, F.A. and Al-obaid, A.M. (2000) Synthesis and Biological Evaluation of Certain α,β-Unsaturated Ketones and Their Corresponding Fused Pyridines as Antiviral and Cytotoxic Agents. Journal of Medicinal Chemistry, 43, 2915-2921. <br/>http://dx.doi.org/10.1021/jm000038m
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577971' target='_blank'>17</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref17" id="ref17"></a>
                                        Olayinka, O.A., Craig, A.O., Obinna, C.N. and David, A.A. (2010) Microwave Assisted Synthesis and Antimicrobial Activity of 2-Quinoxalinone-3-Hydrazone Derivatives. Bioorganic & Medicinal Chemistry, 18, 214-221. 
http://dx.doi.org/10.1016/j.bmc.2009.10.064
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577972' target='_blank'>18</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref18" id="ref18"></a>
                                        Fang, V.S., Minkin, C. and Goldhaber, P. (1971) 2-Thiophenecarboxylic Acid: Inhibitor of Bone Resorption in Tissue Culture. Science, 172, 163-165. http://dx.doi.org/10.1126/science.172.3979.163
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577973' target='_blank'>19</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref19" id="ref19"></a>
                                        Pratt, J.W. (2003) In: Wiley-VCH, Ed., Ullmann’s Encyclopedia of Industrial Chemistry, Vol. 36, Wiley-VCH, Weinheim, 653.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577974' target='_blank'>20</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref20" id="ref20"></a>
                                        Baliah, V. and Jeyaraman, R. (1971) Synthesis of Some 3-Azabicyclo[3.3.1]Nonan-9-One. Indian Journal of Chemistry, 9, 1020-2022.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577975' target='_blank'>21</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref21" id="ref21"></a>
                                        Blois, M.S. (1958) Antioxidant Determinations by the Use of a Stable Free Radical. Nature, 26, 1199-1200. 
http://dx.doi.org/10.1038/1811199a0
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577976' target='_blank'>22</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref22" id="ref22"></a>
                                        Ren, J.Y., Zhao, M.M., Shi, J., Wang, J.S., Jiang, Y.M., Cui, C., et al. (2008) Purification and Identification of Antioxidant Peptides from Grass Carp Muscle Hydrolysates by Consecutive Chromatography and Electrospray Ionization-Mass Spectrometry. Food Chemistry, 108, 727-736. <br/>http://dx.doi.org/10.1016/j.foodchem.2007.11.010
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577977' target='_blank'>23</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref23" id="ref23"></a>
                                        Garratt, C.J. (1964) Effect of Iodination on the Biological Activity of Insulin. Nature, 201, 1324-1325. 
<br/>http://dx.doi.org/10.1038/2011324a0
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577978' target='_blank'>24</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref24" id="ref24"></a>
                                        Mosmann, T. (1983) Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. Journal of Immunological Methods, 65, 55-63.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577979' target='_blank'>25</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref25" id="ref25"></a>
                                        Standar, A., Marais, S., Stivaktas, V., Vorster, C., Albrecht, C., Lottering, M.-L. and Joubert, A.M. (2009) In Vitro Effects of Sutherlandia frutescens Water Extracts on Cell Numbers, Morphology, Cell Cycle Progression and Cell Death in a Tumorigenic and a Non-Tumorigenic Epithelial Breast Cell Line. Journal of Ethnopharmacology, 124, 45-60. 
http://dx.doi.org/10.1016/j.jep.2009.04.013
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577980' target='_blank'>26</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref26" id="ref26"></a>
                                        Dhar, M.H., Dhar, M.M., Dhawan, B.N., Mahrora, B.N. and Ray, C. (1968) Screening of Indian Plants for Biological Activity: I. Indian Journal of Experimental Biology, 6, 232-247.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577981' target='_blank'>27</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref27" id="ref27"></a>
                                        Sylvestre, S. and Pandiarajan, K. (2011) NMR Spectral Study of Some2r,6c-Diarylpiperidine-4-One (3’-Hydroxy-2’- Napthoyl)Hydrazones with Special Reference to γ-Syn Effect. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 78, 153-159. http://dx.doi.org/10.1016/j.saa.2010.09.015
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577982' target='_blank'>28</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref28" id="ref28"></a>
                                        Gladii, Y.P., Omarov, T.T. and Buranbaev, M.Z. (1993) X-Ray Diffraction Study of 2,4-Diphenyl-9-Ethynyl-3-Aza- bicyclo-[3.3.1]Nonan-9-Ol. Journal of Structural Chemistry, 34, 336-338. <br/>http://dx.doi.org/10.1007/BF00761492
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577983' target='_blank'>29</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref29" id="ref29"></a>
                                        WHO (World Health Organization) (2008) World Cancer Report. 1-26.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577984' target='_blank'>30</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref30" id="ref30"></a>
                                        Bray, F., Jemal, A., Grey, N., Ferlayand, J. and Forman, D. (2012) Global Cancer Transitions According to the Human Development Index (2008-2030): A Population-Based Study. Lancet Oncology, 13, 790-801. 
http://dx.doi.org/10.1016/S1470-2045(12)70211-5
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577985' target='_blank'>31</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref31" id="ref31"></a>
                                        Hosono, S., Lee, C.S., Chou, M.J., Yang, C.S. and Shih, C.H. (1999) Molecular Analysis of the p53 Alleles in Primary Hepatocellular Carcinomas and Cell Lines. Oncogene, 6, 237-243.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577986' target='_blank'>32</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref32" id="ref32"></a>
                                        Le Gall, R., Marchand, C. and Rees, J. (2005) Impacts of Antibiotics on in Vitro UVA-Susceptibility of Human Skin Fibroblasts. European Journal of Dermatology, 15, 146-151.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1577987' target='_blank'>33</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref33" id="ref33"></a>
                                        Xaiver, J.J.F., Krishnasamy, K. and Sankar, C. (2012) Synthesis and Antibacterial, Antifungal Activities of Some 2r,4c-Diaryl-3-Azabicyclo[3.3.1]Nonan-9-One-4-Aminobenzoyl Hydrazones. Medicinal Chemistry Research, 21, 345- 350. http://dx.doi.org/10.1007/s00044-010-9528-6
                                    </td>
                                </tr>
                            
                    </table>
                </p>
            </div>

        </div>





    

    
    <link href="//www.scirp.org/css/html.css?timestamp=202411141045303414" rel="stylesheet" type="text/css" />
    
    <script type="text/javascript" src="//www.scirp.org/js/lazyload.js?timestamp=202411141045303414"></script>
    <script type="text/javascript" src="//www.scirp.org/js/ref.js?timestamp=202411141045303414"></script>
    


    <script type="text/javascript"  src="//www.scirp.org/js/htmlinsert.js?timestamp=202411141045303414"></script>
<script type="text/javascript" >

    window.onload = function () {
        var device = tools.currDevice()
        // ipad mobile 和 ipad true
        // iphone mobile 和 iphone true
        // android mobile 和 android true
        if (device.isMobile && (device.iphone || device.android)) {
            return false;
        }
        tools.replaceNode()
    }
</script>


<script src="//www.scirp.org/js/crossmark_widget.js" type="text/javascript"></script>

                    </div>
                </div>

                <div class="col-md-3 column col-md-pull-9">
                    <div class="row clearfix bg_w visible-md visible-lg">
                        <div class="title_up">Journals Menu</div>
                        <div class="column txt3">
                            

<ul class="list-unstyled">
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/journalarticles?journalid=790" target="_top">&nbsp;&nbsp;Articles</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/home?journalid=790" target="_top">&nbsp;&nbsp;Archive</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/indexing?journalid=790" target="_top">&nbsp;&nbsp;Indexing</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/aimscope?journalid=790" target="_top">&nbsp;&nbsp;Aims & Scope</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/editorialboard?journalid=790"  target="_top">&nbsp;&nbsp;Editorial Board</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/forauthors?journalid=790"  target="_top">&nbsp;&nbsp;For Authors</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/apc?journalid=790" target="_top">&nbsp;&nbsp;Publication Fees</a></li>
</ul>

                        </div>
                    </div>

                    <div class="row clearfix bg_w visible-xs visible-sm">
                        <div class="panel-group column" id="accordion" style="margin-bottom: 0;">
                            <div class="panel panel-default" style="border: none;">
                                <div class="panel-heading" style="background: #fff; padding: 0; margin: 0;">
                                    <h4 class="panel-title">
                                        <a class="link1" data-toggle="collapse" data-parent="#accordion" href="#collapse1">Journals Menu&nbsp;&nbsp;<i class="fa fa-angle-down"></i>
                                        </a>
                                    </h4>
                                </div>
                                <div id="collapse1" class="panel-collapse collapse">
                                    <div class="panel-body txt3" style="padding: 10px 0 0 0;">
                                        

<ul class="list-unstyled">
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/journalarticles?journalid=790" target="_top">&nbsp;&nbsp;Articles</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/home?journalid=790" target="_top">&nbsp;&nbsp;Archive</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/indexing?journalid=790" target="_top">&nbsp;&nbsp;Indexing</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/aimscope?journalid=790" target="_top">&nbsp;&nbsp;Aims & Scope</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/editorialboard?journalid=790"  target="_top">&nbsp;&nbsp;Editorial Board</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/forauthors?journalid=790"  target="_top">&nbsp;&nbsp;For Authors</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/apc?journalid=790" target="_top">&nbsp;&nbsp;Publication Fees</a></li>
</ul>

                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>

                     
                    <div id="relatedArticles"></div>
                    <div id="div_sep" class="row clearfix bg_w">
                       

<div class="column left_link1">
    <ul class="list-unstyled">
        <li><a href="../journal/openspecialissues?journalid=790&PubState=false" target="_blank">
            Open Special Issues</a></li>
        <li><a href="../journal/openspecialissues?journalid=790&PubState=true" target="_blank">
            Published Special Issues</a></li>
        <li><a href="../journal/openspecialissuesguideline?journalid=790" target="_blank">
            Special Issues Guideline</a></li>
    </ul>
</div>

                    </div>
                    

<div class="row clearfix bg_w">
    <div class="column right_link1">
        <ul class="list-unstyled">
            <li><a href="../journal/newslettersubscription?journalid=790" target="_blank">
                E-Mail Alert</a></li>            
            <li><a href="../journal/subscribejournal?journalid=790" target="_blank">OJMC
                Subscription</a></li>
            <li><a href="../journal/publicat_ethics_statement?journalid=790" target="_blank">
                Publication Ethics & OA Statement</a></li>
            <li><a href="../journal/faq?journalid=790" target="_blank">
                Frequently Asked Questions</a></li>
            <li><a href="../journal/recommendtopeers?journalid=790" target="_blank">
                Recommend to Peers</a></li>
            <li><a href="../journal/recommendtolibrary?journalid=790" target="_blank">
                Recommend to Library</a></li>
            <li><a href="../journal/contactus?journalid=790" target="_blank">
                Contact us</a></li>
            <li id="UserControl_Reacommend_div_ojuDisclaimer" style="DisPlay:None;"><a href="../journal/disclaimer?journalid=790" target="_blank">
                Disclaimer</a></li>
            <li id="UserControl_Reacommend_div_historyIssue" style="DisPlay:None;"><a href="../journal/historyissue?journalid=790" target="_blank">
                History Issue</a></li>
        </ul>
    </div>
</div>


                    <div id="journalSponsors"></div>

                    
                    <div class="row clearfix bg_w">
                        



<div class="column">
    <div class="title_up">Follow SCIRP</div>
    <div style="padding-top: 10px;">
        <table width="100%" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td align="left"><a href="https://twitter.com/Scirp_Papers" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Twitter" target="_blank">
                    <img src="../images/Twitter.svg" height="30" alt="Twitter"></a></td>
                <td align="left"><a href="https://www.facebook.com/Scientific-Research-Publishing-267429817016644/" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Facebook" target="_blank">
                    <img src="../images/fb.svg" height="30" alt="Facebook"></a></td>
                <td align="left"><a href="https://www.linkedin.com/company/scientific-research-publishing/" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Linkedin" target="_blank">
                    <img src="../images/in.svg" height="30" alt="Linkedin"></a></td>
                <td align="left"><a href="http://e.weibo.com/scirp" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Weibo" target="_blank">
                    <img src="../images/weibo.svg" height="30" alt="Weibo"></a></td>
                
            </tr>
        </table>
    </div>
</div>


                    </div>
                    <div class="row clearfix bg_w">
                        



<div class="column">
    <div class="title_up">Contact us</div>
    <div style="padding-top: 5px;">
        <table width="100%" border="0" cellspacing="0" cellpadding="0">
             <tr>
                <td style="text-align:left; width:25px;" ><img border='0' src="../images/phone02.jpg"  style="float: left;" /></td>
                <td style="padding-left:5px;">+1 323-425-8868</td>           
            </tr>
            <tr>
                <td style="text-align:left; width:25px;" ><img border='0' src="../images/emailsrp.png"  style="float: left;" /></td>
                <td style="padding-left:5px;"><a href="mailto:customer@scirp.org" target="_blank">customer@scirp.org</a></td>           
            </tr>
            <tr>
                <td><img border='0' src="../images/whatsapplogo.jpg" alt='WhatsApp' title='WhatsApp' style="float: left;" /></td>
                <td style="padding-left:5px;">+86 18163351462(WhatsApp)</td>
            </tr>
            <tr>
                <td><a target='_blank' href='http://wpa.qq.com/msgrd?v=3&uin=1655362766&site=qq&menu=yes' rel="nofollow"><img border='0' src="../Images/qq25.jpg" alt='Click here to send a message to me' title='Click here to send a message to me' style="float: left;" /></a></td>
                <td style="padding-left:5px;"><a target='_blank' href='http://wpa.qq.com/msgrd?v=3&uin=1655362766&site=qq&menu=yes' rel="nofollow">1655362766</a></td>
            </tr>
            <tr>
                <td style="vertical-align:top;"><img border='0' src="../images/weixinlogo.jpg"  /></td>
                <td style="padding-left:5px;"><img border='0' src="../images/weixinsrp120.jpg"  /></td>
            </tr>
            <tr>
                <td></td>
                <td style="padding-left:5px;">Paper Publishing WeChat</td>
            </tr>
        </table>
    </div>
</div>







                    </div>
                </div>

            </div>

        </div>

        <div id="papercopyright">
            <div id="UserControl_PaperCopyRight_div_showby" class="clearfix text-center" style="border-top: #ccc 2px solid; background: #fff; padding: 10px; margin-top: 10px; font-size: 12px;">
    <p>Copyright &copy; 2025 by authors and Scientific Research Publishing Inc. </p>
    <p><a rel="license" href="http://creativecommons.org/licenses/by/4.0/"><img alt="Creative Commons License" title="Creative Commons License" style="border-width: 0" src="../Images/ccby.png" width="88" height="31" /></a></p>
    <p>This work and the related PDF file are licensed under a <a about="http://dx.doi.org/10.4236/ojmc.2015.53004" rel="license" href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</a>.</p>
</div>


        </div>
        <div id="footer">
            



<div style="border-top: #d71318 8px solid; padding: 20px 0; margin-top: 20px;">
    <div class="container row clearfix center-block" style="padding: 0;">
        

<script type="text/javascript">
    function checksubscribe() {
        
        var email = $("#UserControl_footer_UserControl_NewsletterSubscription_TextBox_nls_email").val();//Email   id=UserControl_NewsletterSubscription_TextBox_email       
        if (email == "" || email == "E-mail address") {
            alert('Please enter an email address!');
            return false;
        }
        var emailRegExp = new RegExp("[a-z0-9!#$%&'*+/=?^_`{|}~-]+(?:\.[a-z0-9!#$%&'*+/=?^_`{|}~-]+)*@(?:[a-z0-9](?:[a-z0-9-]*[a-z0-9])?\.)+[a-z0-9](?:[a-z0-9-]*[a-z0-9])?");
        if (!emailRegExp.test(email) || email.indexOf('.') == -1) {
            alert('The email address that you entered is invalid!');
            return false;
        }
        return true;
    }
</script>

<div class="col-sm-3 column" style="padding-right: 30px;">
    <span style="margin-bottom: 10px; font-size: 16px; line-height: 1.2em;"><strong>Free SCIRP Newsletters</strong></span>
    <div style="background: #dddddd; border-radius: 6px; box-shadow: 3px 3px 0px #9f9f9f; padding: 10px; margin-bottom: 10px;">

        <div role="form" class="form-inline">
            <div id="UserControl_footer_UserControl_NewsletterSubscription_panel_newsletter">
	
                <div class="form-group" style="margin-bottom: 5px;">
                    <span for="name" style="font-size: 12px; line-height: 1.5em; font-weight: bold;">Add your e-mail address to receive free newsletters from SCIRP.</span>

                    <input name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$TextBox_nls_email" type="text" value="E-mail address" id="UserControl_footer_UserControl_NewsletterSubscription_TextBox_nls_email" class="form-control" onFocus="javascript:if(this.value==&#39;E-mail address&#39;) {this.value=&#39;&#39;;}" onBlur="javascript:if(this.value==&#39;&#39;){this.value=&#39;E-mail address&#39;;}" style="width: 100%; background: #fff; border: #2f2f2f 1px solid; border-radius: 0; height: 25px;" />
                </div>

                <div class="form-group" style="margin-bottom: 5px; width: 100%;">

                    <select name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$DropDownList_journal" id="UserControl_footer_UserControl_NewsletterSubscription_DropDownList_journal" class="form-control" style="width: 100%; height: 25px; border: #2f2f2f 1px solid; border-radius: 0; padding: 0 8px; color: #999;">
		<option value="0">Select Journal</option>
		<option value="737">AA</option>
		<option value="1408">AAD</option>
		<option value="1406">AAR</option>
		<option value="1002">AASoci</option>
		<option value="2423">AAST</option>
		<option value="164">ABB</option>
		<option value="611">ABC</option>
		<option value="1478">ABCR</option>
		<option value="473">ACES</option>
		<option value="492">ACS</option>
		<option value="1579">ACT</option>
		<option value="2437">AD</option>
		<option value="2442">ADR</option>
		<option value="2444">AE</option>
		<option value="2426">AER</option>
		<option value="2316">AHS</option>
		<option value="803">AID</option>
		<option value="1000">AiM</option>
		<option value="476">AIT</option>
		<option value="203">AJAC</option>
		<option value="2422">AJC</option>
		<option value="1304">AJCC</option>
		<option value="535">AJCM</option>
		<option value="884">AJIBM</option>
		<option value="532">AJMB</option>
		<option value="529">AJOR</option>
		<option value="207">AJPS</option>
		<option value="996">ALAMT</option>
		<option value="1517">ALC</option>
		<option value="2317">ALS</option>
		<option value="160">AM</option>
		<option value="477">AMI</option>
		<option value="675">AMPC</option>
		<option value="1573">ANP</option>
		<option value="1574">APD</option>
		<option value="743">APE</option>
		<option value="513">APM</option>
		<option value="1575">ARS</option>
		<option value="2445">ARSci</option>
		<option value="191">AS</option>
		<option value="812">ASM</option>
		<option value="260">BLR</option>
		<option value="2455">CC</option>
		<option value="136">CE</option>
		<option value="2074">CellBio</option>
		<option value="1493">ChnStd</option>
		<option value="122">CM</option>
		<option value="989">CMB</option>
		<option value="92">CN</option>
		<option value="2033">CRCM</option>
		<option value="173">CS</option>
		<option value="1492">CSTA</option>
		<option value="2438">CUS</option>
		<option value="1518">CWEEE</option>
		<option value="2454">Detection</option>
		<option value="2457">EMAE</option>
		<option value="64">ENG</option>
		<option value="93">EPE</option>
		<option value="1311">ETSN</option>
		<option value="2315">FMAR</option>
		<option value="208">FNS</option>
		<option value="2432">GEP</option>
		<option value="2462">GIS</option>
		<option value="541">GM</option>
		<option value="1690">Graphene</option>
		<option value="512">GSC</option>
		<option value="65">Health</option>
		<option value="103">IB</option>
		<option value="176">ICA</option>
		<option value="111">IIM</option>
		<option value="490">IJAA</option>
		<option value="2449">IJAMSC</option>
		<option value="1391">IJCCE</option>
		<option value="202">IJCM</option>
		<option value="4">IJCNS</option>
		<option value="209">IJG</option>
		<option value="2428">IJIDS</option>
		<option value="747">IJIS</option>
		<option value="1261">IJMNTA</option>
		<option value="1578">IJMPCERO</option>
		<option value="1519">IJNM</option>
		<option value="527">IJOC</option>
		<option value="1477">IJOHNS</option>
		<option value="1298">InfraMatics</option>
		<option value="1980">JACEN</option>
		<option value="2436">JAMP</option>
		<option value="525">JASMI</option>
		<option value="475">JBBS</option>
		<option value="2443">JBCPR</option>
		<option value="30">JBiSE</option>
		<option value="2435">JBM</option>
		<option value="230">JBNB</option>
		<option value="162">JBPC</option>
		<option value="2431">JCC</option>
		<option value="530">JCDSA</option>
		<option value="526">JCPT</option>
		<option value="125">JCT</option>
		<option value="2425">JDAIP</option>
		<option value="479">JDM</option>
		<option value="531">JEAS</option>
		<option value="691">JECTC</option>
		<option value="29">JEMAA</option>
		<option value="144">JEP</option>
		<option value="1986">JFCMV</option>
		<option value="1395">JFRM</option>
		<option value="114">JGIS</option>
		<option value="2461">JHEPGC</option>
		<option value="2421">JHRSS</option>
		<option value="1411">JIBTVA</option>
		<option value="102">JILSA</option>
		<option value="175">JIS</option>
		<option value="648">JMF</option>
		<option value="397">JMGBND</option>
		<option value="1753">JMMCE</option>
		<option value="172">JMP</option>
		<option value="2433">JPEE</option>
		<option value="591">JQIS</option>
		<option value="990">JSBS</option>
		<option value="45">JSEA</option>
		<option value="543">JSEMAT</option>
		<option value="339">JSIP</option>
		<option value="2430">JSS</option>
		<option value="28">JSSM</option>
		<option value="478">JST</option>
		<option value="2439">JTR</option>
		<option value="2460">JTST</option>
		<option value="357">JTTs</option>
		<option value="46">JWARP</option>
		<option value="210">LCE</option>
		<option value="1485">MC</option>
		<option value="163">ME</option>
		<option value="787">MI</option>
		<option value="786">MME</option>
		<option value="917">MNSMS</option>
		<option value="815">MPS</option>
		<option value="2441">MR</option>
		<option value="1487">MRC</option>
		<option value="1576">MRI</option>
		<option value="174">MSA</option>
		<option value="2434">MSCE</option>
		<option value="528">NJGC</option>
		<option value="205">NM</option>
		<option value="192">NR</option>
		<option value="69">NS</option>
		<option value="2459">OALib</option>
		<option value="2463">OALibJ</option>
		<option value="2453">ODEM</option>
		<option value="738">OJA</option>
		<option value="1480">OJAB</option>
		<option value="1590">OJAcct</option>
		<option value="814">OJAnes</option>
		<option value="1407">OJAP</option>
		<option value="1479">OJApo</option>
		<option value="1003">OJAppS</option>
		<option value="2446">OJAPr</option>
		<option value="601">OJAS</option>
		<option value="806">OJBD</option>
		<option value="785">OJBIPHY</option>
		<option value="2447">OJBM</option>
		<option value="2452">OJC</option>
		<option value="997">OJCB</option>
		<option value="606">OJCD</option>
		<option value="788">OJCE</option>
		<option value="792">OJCM</option>
		<option value="1977">OJD</option>
		<option value="810">OJDer</option>
		<option value="586">OJDM</option>
		<option value="614">OJE</option>
		<option value="1577">OJEE</option>
		<option value="2456">OJEM</option>
		<option value="811">OJEMD</option>
		<option value="816">OJEpi</option>
		<option value="1979">OJER</option>
		<option value="736">OJF</option>
		<option value="1004">OJFD</option>
		<option value="587">OJG</option>
		<option value="817">OJGas</option>
		<option value="613">OJGen</option>
		<option value="602">OJI</option>
		<option value="592">OJIC</option>
		<option value="593">OJIM</option>
		<option value="793">OJINM</option>
		<option value="1186">OJL</option>
		<option value="588">OJM</option>
		<option value="790">OJMC</option>
		<option value="784">OJMetal</option>
		<option value="739">OJMH</option>
		<option value="820">OJMI</option>
		<option value="612">OJMIP</option>
		<option value="742">OJML</option>
		<option value="999">OJMM</option>
		<option value="822">OJMN</option>
		<option value="998">OJMP</option>
		<option value="596">OJMS</option>
		<option value="2424">OJMSi</option>
		<option value="605">OJN</option>
		<option value="821">OJNeph</option>
		<option value="804">OJO</option>
		<option value="604">OJOG</option>
		<option value="2464">OJOGas</option>
		<option value="1978">OJOp</option>
		<option value="805">OJOph</option>
		<option value="794">OJOPM</option>
		<option value="823">OJOTS</option>
		<option value="813">OJPathology</option>
		<option value="589">OJPC</option>
		<option value="791">OJPChem</option>
		<option value="609">OJPed</option>
		<option value="610">OJPM</option>
		<option value="741">OJPP</option>
		<option value="744">OJPS</option>
		<option value="603">OJPsych</option>
		<option value="807">OJRA</option>
		<option value="789">OJRad</option>
		<option value="824">OJRD</option>
		<option value="1394">OJRM</option>
		<option value="590">OJS</option>
		<option value="735">OJSS</option>
		<option value="600">OJSST</option>
		<option value="607">OJST</option>
		<option value="1486">OJSTA</option>
		<option value="2448">OJTR</option>
		<option value="808">OJTS</option>
		<option value="509">OJU</option>
		<option value="1001">OJVM</option>
		<option value="547">OPJ</option>
		<option value="71">POS</option>
		<option value="206">PP</option>
		<option value="2440">PST</option>
		<option value="148">PSYCH</option>
		<option value="2450">SAR</option>
		<option value="533">SCD</option>
		<option value="135">SGRE</option>
		<option value="474">SM</option>
		<option value="1589">SN</option>
		<option value="491">SNL</option>
		<option value="2034">Soft</option>
		<option value="204">SS</option>
		<option value="666">TEL</option>
		<option value="104">TI</option>
		<option value="1405">UOAJ</option>
		<option value="2458">VP</option>
		<option value="146">WET</option>
		<option value="511">WJA</option>
		<option value="818">WJCD</option>
		<option value="502">WJCMP</option>
		<option value="809">WJCS</option>
		<option value="2451">WJET</option>
		<option value="506">WJM</option>
		<option value="615">WJNS</option>
		<option value="493">WJNSE</option>
		<option value="534">WJNST</option>
		<option value="510">WJV</option>
		<option value="41">WSN</option>
		<option value="2465">YM</option>

	</select>


                </div>

                <input type="submit" name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$btnSubscribe" value="Subscribe" onclick="return checksubscribe();" id="UserControl_footer_UserControl_NewsletterSubscription_btnSubscribe" class="btn btn-default" style="background: #2f2f2f; border-radius: 5px; color: #fff; padding: 2px 4px;" />


            
</div>


        </div>

    </div>

</div>

        <div class="col-sm-9 column">
        



    <div class="row clearfix foot_links">
        <div class="col-sm-3 col-xs-6 column f_link1" style="margin-bottom: 10px;">
            <ul class="list-unstyled" >
                <li><h4><strong><a href="//www.scirp.org/" target="_top">Home</a></strong></h4></li>
                <li><a href="../journal/indexbytitle" target="_blank">Journals A-Z</a></li>
                <li><a href="../journal/" target="_blank">Subject</a></li>
                <li><a href="../book/" target="_blank">Books</a></li>
                <li><a href="../sitemap/index.xml" target="_blank">Sitemap</a></li>
                <li><a href="../aboutus/#contactus" target="_blank">Contact Us</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link1" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/aboutus/" target="_blank">About SCIRP</a></strong></h4></li>
                <li><a href="../aboutus/publicationfees" target="_blank">Publication Fees</a></li>
                <li><a href="../aboutus/forauthors" target="_blank">For Authors</a></li>
                <li><a href="../journal/peer-review" target="_blank">Peer-Review Issues</a></li>
                <li><a href="../journal/callforspecialissueproposals" target="_blank">Special Issues</a></li>
                <li><a href="../news/" target="_blank">News</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link2" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/careers/" target="_blank">Service</a></strong></h4></li>
                <li><a href="//papersubmission.scirp.org" target="_blank">Manuscript Tracking System</a></li>
                <li><a href="../aboutus/subscription" target="_blank">Subscription</a></li>
                <li><a href="../author/" target="_blank">Translation & Proofreading</a></li>
                <li><a href="../aboutus/faq" target="_blank">FAQ</a></li>
                <li><a href="//www.scirp.org/journalvolume.html" target="_blank">Volume & Issue</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link3" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/aboutus/policies" target="_blank">Policies</a></strong></h4></li>
                <li><a href="../journal/openaccess" target="_blank">Open Access</a></li>
                <li><a href="../aboutus/publicationethics" target="_blank">Publication Ethics</a></li>
                <li><a href="../aboutus/preservation" target="_blank">Preservation</a></li>
                <li><a href="../aboutus/retraction" target="_blank">Retraction</a></li>
                <li><a href="../aboutus/privacypolicy" target="_blank">Privacy Policy</a></li>
            </ul>
        </div>
    </div>


            </div>
    </div>
</div>





<div style="background: #dddddd; line-height: 2em; padding: 10px; color: #666;">
    <div class="text-center">
        Copyright &copy; 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.    
    </div>
</div>

<a href="#0" class="cd-top">Top</a>





        </div>

        <input type="hidden" name="ctl00$Hidden_JournalID" id="Hidden_JournalID" />
    </form>



        <script type="text/javascript">
            $.ajax({
                type: "GET",
                url: "relatedarticles?paperid=" +60062 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {
                $("#relatedArticles").html(msg);
            }
        });
    </script>

    <script type="text/javascript">
        $.ajax({
            type: "GET",
            url: "journalsponsor?journalid=" +790 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {
                $("#journalSponsors").html(msg);
            }
        });
    </script>





    <script type="text/javascript">
        $.ajax({
            type: "GET",
            url: "paperviewsdownloads?journalid=" +790 +"&paperid=" +60062 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {

            }
        });
    </script>






    <!-- jQuery Frameworks    ============================================= -->
    <script src="//www.scirp.org/js/jquery-1.12.4.min.js" type="text/javascript"></script>
    <script src="//www.scirp.org/js/bootstrap.min.js" type="text/javascript"></script>
    <script src="//www.scirp.org/js/main.js" type="text/javascript"></script>
    <script type="text/javascript"  defer="defer" src="//www.scirp.org/js/gtm.js"></script>

   


<script type="text/javascript" src="//www.scirp.org/js/viewer.min.js"></script>
<link rel="stylesheet" href="//www.scirp.org/css/viewer.min.css"  />
<script type="text/javascript">
    $(function () {
        try {
            $("img.lazy").lazyload();
        } catch (e) {

        }

    });
    $(function () {
        try {
            var images = document.querySelectorAll('.lazy');
            images.forEach(function (image) {
                new Viewer(image, {
                    // 在这里定义您的 Viewer 配置选项，和之前示例相同
                    title: false,
                    navbar: false,
                    // ...其他配置
                });
            });
        } catch (e) {

        }

    });
</script>


</body>



</html>
